Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.140
+0.030 (2.70%)
At close: Aug 14, 2026, 4:00 PM EDT
1.130
-0.010 (-0.88%)
After-hours: Aug 14, 2026, 4:10 PM EDT
Marker Therapeutics Market Cap
Marker Therapeutics has a market cap or net worth of $19.01 million as of August 14, 2026. Its market cap has increased by 30.19% in one year.
Market Cap
19.01M
Enterprise Value
4.09M
1-Year Change
30.19%
Ranking
Category
Stock Price
$1.14
ChartMarket Cap Chart
Since November 8, 2016, Marker Therapeutics's market cap has decreased from $45.80M to $19.01M, a decrease of -58.50%. That is a compound annual growth rate of -8.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 19.01M | -23.36% |
| Dec 31, 2025 | 24.80M | -10.79% |
| Dec 31, 2024 | 27.80M | -43.15% |
| Dec 29, 2023 | 48.90M | 120.27% |
| Dec 30, 2022 | 22.20M | -71.86% |
| Dec 31, 2021 | 78.90M | 13.36% |
| Dec 31, 2020 | 69.60M | -47.15% |
| Dec 31, 2019 | 131.70M | -47.70% |
| Dec 31, 2018 | 251.80M | 509.69% |
| Dec 29, 2017 | 41.30M | 27.08% |
| Dec 30, 2016 | 32.50M | -29.04% |
| Nov 8, 2016 | 45.80M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Celularity | 20.13M |
| Polyrizon | 20.12M |
| Cellectar Biosciences | 19.82M |
| NewcelX | 19.38M |
| Skye Bioscience | 19.01M |
| Palatin Technologies | 18.84M |
| Werewolf Therapeutics | 18.76M |
| Tempest Therapeutics | 18.70M |